Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm	Recruiting	Not applicable	2026-06-25		NCT07669298

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centre Hospitalier Universitaire Dupuytren de Limoges (CHUL)	1
Haukeland University Hospital	163
Helse Stavanger HF	67
Hospital Clinic of Barcelona	95
Karolinska Institutet	493
Leuven University Medical Center	2
Maria Sklodowska-Curie National Research Institute of Oncology	28
Medical University of Gdansk	56
Northern Norway Regional Health Trust	2
Sorlandet Hospital HF	42
St. Olavs Hospital	167
University Hospital, Akershus	87
University Hospital, Ghent	163
University of Oslo	116
University of Roma La Sapienza	73
Universitätsklinikum Hamburg-Eppendorf	136
Vestre Viken Hospital Trust	60

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institute of Oncology in Warsaw	Warsaw	Poland	1
University Clinical Centre	Gdansk	Poland	1
University Hospital, Limoges	Limoges	France	2